Results

Total Results: 468 records

Showing results for "vascular".

261. Effectiveness of Treatments for Diabetic Peripheral Neuropathy (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/diabetic-neuropathy_research-protocol.pdf
     May 09, 2016 - These agents may also contribute to preventing DPN complications,13 since co-existing peripheral vascular … because they are prescribed for other indications (hypercholesterolemia, hypertension and/or periperhal vascular

262. Preventing Complications and Treating Symptoms of Diabetic Peripheral Neuropathy | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/diabetic-neuropathy/research-2017
     April 01, 2020 - Skip to main content An official website of the Department of Health & Human Services Careers Contact Us Español FAQs Effective Health Care Program Powered by the Evidence-based Practice Centers …

263. CERs Report cover (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/future05-breastcancer-10-5-2010final.pdf
     September 01, 2010 - Regulation of the vascular endothelial growth factor and growth by estrogen and antiestrogens through … Assessment of vascular effects of tamoxifen and its metabolites on the rat perfused hindquarter vascular … Vascular Pharmacology 2009 Jan-Feb;50(1-2):40-44. 257. … With special reference to the actions of SERM on the skin and vascular elasticity]. … Arteriosclerosis, Thrombosis & Vascular Biology 2010 May;30(5):992-999. 284.

264. Diabetes-Drugs-Utilization Research (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/diabetes-drugs-utilization_research.pdf
     March 01, 2011 - Diabetes Vascular Res 2009;6(3):146-52. 11. Food and Drug Administration.

265. Diabetes-Foot-Ulcer-Amputation-Incidence Research (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/diabetes-foot-ulcer-amputation-incidence_research.pdf
     January 01, 2011 - complications are of- ten categorized as microvascular (e.g., nephropathy, retinopathy) and macro- vascular

266. Pressure-Ulcer-Treatment Executive (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/pressure-ulcer-treatment_executive.pdf
     May 01, 2013 - cord injury), wound environments (e.g., incontinence), and wound healing (e.g., diabetes and vascular … specific known risk factors for pressure ulcers (e.g., nutritional status, incontinence, peripheral vascular … specific known risk factors for pressure ulcers (e.g., nutritional status, incontinence, peripheral vascular

267. Disposition of Comments for CER 171 Noninvasive Testing for Coronary Artery Disease (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/coronary-artery-disease-testing_disposition-comments.pdf
     March 29, 2016 - demonstrates the analytic framework and the key questions, there is not an explicit statement that vascular … However, vascular complications are represented in the larger table on p16 in the inclusion table. … We did abstract any information on vascular complications such as stroke; this has been added to the

268. Layout 1 (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/osteoarthritis-pain_executive.pdf
     October 01, 2011 - with increased risk of major GI and other extracranial bleeding when given for primary prevention of vascular … CV harms: Aspirin reduced the risk of vascular events in a collaborative meta-analysis of individual

269. Future Research Needs Document (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/breast-cancer-risk-reduction_research.pdf
     October 25, 2010 - Regulation of the vascular endothelial growth factor and growth by estrogen and antiestrogens through … Assessment of vascular effects of tamoxifen and its metabolites on the rat perfused hindquarter vascular … Vascular Pharmacology 2009 Jan-Feb;50(1-2):40-44. 257. … With special reference to the actions of SERM on the skin and vascular elasticity]. … Arteriosclerosis, Thrombosis & Vascular Biology 2010 May;30(5):992-999. 284.

270. Cannabis-2023-Surv-Rep-4-Table-E-5 (xls file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cannabis-2023-surv-rep-4-table-E-5.xlsx
     January 01, 2023 - 0.32 to 0.71) Psychiatric disorders: 4.2% (14/337) vs. 14.8% (50/337), RR 0.28 (95% CI 0.16 to 0.50) Vascular

271. Cannabis-2022-Surv-Rep-4-Table-F5 (xls file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cannabis-2022-surv-rep-4-table-F5.xlsx
     January 01, 2022 - 0.32 to 0.71) Psychiatric disorders: 4.2% (14/337) vs. 14.8% (50/337), RR 0.28 (95% CI 0.16 to 0.50) Vascular

272. Since their introduction in 20xx, DES have been shown in clinical trials to decrease TLR (… (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/coronary-stents-outcomes_research.pdf
     January 01, 2010 - Eisenstein: Research support from Medtronic Vascular and Eli Lilly Ghazala Haque: None David Dai: None … 9930(22.1%) <0.001 22.8 23.0 NS Insulin 20430 (9.4%) 4533 (10.1%) <0.001 9.5 9.6 NS Peripheral Vascular

273. Disposition of Comments Report for Acute Migraine Treatment in Emergency Settings (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/migraine-emergency_disposition-comments.pdf
     November 27, 2012 - , the potential for adverse effects of the triptans might be higher, especially for patients with vascular … The potential for adverse effects of the triptans might be more explicitly stated with regards to vascular

274. Kidney-Disease-Medicine Surveillance (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/kidney-disease-medicine_surveillance.pdf
     October 01, 2012 - SCEPC Low-protein diets did not significantly reduce risk of mortality, ESRD, or any clinical vascular … Low-protein diets did not significantly reduce risk of mortality, ESRD, or any clinical vascular

275. Research Protocol: Care Interventions for PeopleWith Dementia (PWD) and Their Caregivers (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/pwd-care-interventions-protocol.pdf
     February 22, 2019 - disease is the most common form of progressive dementia and— grouped with Lewy body, frontotemporal, vascular … ADRD – Alzheimer’s disease related dementias (i.e., frontotemporal dementia, Lewy body dementia, and vascular

276. Care Interventions for People Living With Dementia and Their Caregivers | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/care-interventions-pwd/protocol
     August 01, 2020 - disease is the most common form of progressive dementia and—grouped with Lewy body, frontotemporal, vascular … ADRD=Alzheimer's disease related dementias (i.e., frontotemporal dementia, Lewy body dementia, and vascular

277. CER 45 Self-Measured Blood Pressure Monitoring Comparative Effectiveness Surveillance Final 4.7.16 (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/measuring-blood-pressure-surveillance-160412.pdf
     April 11, 2016 - myocardial"infarction,"angina,"congestive"heart"failure," stroke,"transient"ischemic"attack,"peripheral"vascular"disease"diagnosis"or … Urinary"potassium"excretion"and"risk"of"developing" hypertension:"the"prevention"of"renal"and"vascular"end'stage"disease"study … "Chronic"distress"and"acute"vascular"stress"responses"associated"with" ambulatory"blood"pressure"in"low'testosterone"African"men … Internet"based" vascular"risk"factor"management"for"patients"with"clinically"manifest"vascular"disease

278. Future Research Needs for Angiotensin-Converting Enzyme Inhibitors (ACEIs), Angiotensin II Receptor Antagonists (ARBs), or Direct Renin Inhibitors (DRIs) for Treating Hypertension (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/ace-inhibitor-arb-future_research.pdf
     March 01, 2012 - Age-specific relevance of usual blood pressure to vascular mortality: a meta- analysis of individual … This approach may be particularly useful for infrequent outcomes such as vascular events, new diagnoses … Age-specific relevance of usual blood pressure to vascular mortality: a meta- analysis of individual … has significant clinical overlap with related conditions such as ischemic heart disease, peripheral vascular

279. Type-2-Diabetes-Medications-Update Surveillance (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/type-2-diabetes-medications-update_surveillance.pdf
     December 31, 2013 - patients with Type 2 diabetes well controlled on metformin monotherapy improves several markers of vascular … Metformin monotherapy RCT 44 patients on a stable dosage of metformin 12 weeks Change in HbA1, vascular … effects (laboratory markers characterizin g vascular and endothelial function) HbA1c declined … change could be observed for high-sensitivity C-reactive protein, monocyte chemotactic protein 1, vascular

280. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/heart-disease-ace-inhibitor-arb-disposition.pdf
     March 10, 2010 - We felt that cardiovascular mortality (which included death from vascular causes such as stroke) was